Axel S Merseburger

8PUBLICATIONS
56CO-AUTHORS
Predictive and prognostic markersPopular and genre literatureCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 10, 2026
Cancer-Control Outcomes of Japanese Vs. German Metastatic Hormone-Sensitive Prostate Cancer Patients: A Real-World Cross-Country Comparison of Patients Undergoing Combination Therapies.

|Nov 19, 2025
Using ChatGPT-4 for Lay Summarization in Prostate Cancer Research to Advance Patient-Centered Communication: Large-Scale Generative AI Performance Evaluation.

Emily Rinderknecht, Simon U Engelmann, Veronika Saberi

|Aug 01, 2025
Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study.

Amit Bahl, Andrew Chilelli, Rita Faria

|Jun 28, 2024
Targeted Investigational Treatment Analysis of Novel Anti-androgen (TITAN) study: ultralow prostate-specific antigen decline with apalutamide plus androgen-deprivation therapy.

Axel S Merseburger, Neeraj Agarwal, Anders Bjartell

|Mar 14, 2024
Cardiovascular disease risk assessment and multidisciplinary care in prostate cancer treatment with ADT: recommendations from the APMA PCCV expert network.

Axel S Merseburger, Ganesh Bakshi, Dong-Yi Chen

|Mar 03, 2023
Radiomics vs radiologist in prostate cancer. Results from a systematic review.

Giuseppe Chiacchio, Daniele Castellani, Carlotta Nedbal

Pageof 2

Frequent Collaborators

2 joint publications

Nigel Rozario

2 joint publications

Robert Snijder

2 joint publications

Rita Faria

2 joint publications

Andrew Chilelli